M
Mitsuyoshi Nakashima
Researcher at Hamamatsu University School of Medicine
Publications - 274
Citations - 5537
Mitsuyoshi Nakashima is an academic researcher from Hamamatsu University School of Medicine. The author has contributed to research in topics: Pharmacokinetics & Cmax. The author has an hindex of 36, co-authored 274 publications receiving 5342 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial
Hidehiko Saito,Ikuro Maruyama,Shuji Shimazaki,Yasuhiro Yamamoto,Naoki Aikawa,R. Ohno,A. Hirayama,Tamotsu Matsuda,Hidesaku Asakura,Mitsuyoshi Nakashima,Nobuo Aoki +10 more
TL;DR: When compared with heparin therapy, ART‐123 therapy more significantly improves DIC and alleviates bleeding symptoms in DIC patients.
Journal ArticleDOI
Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial
Nigishi Hotta,Yasuo Akanuma,Ryuzo Kawamori,Kempei Matsuoka,Yoshitomo Oka,Motoaki Shichiri,Takayoshi Toyota,Mitsuyoshi Nakashima,Isao Yoshimura,Nobuo Sakamoto,Yukio Shigeta +10 more
TL;DR: Long-term treatment with epalrestat is well tolerated and can effectively delay the progression of diabetic neuropathy and ameliorate the associated symptoms of the disease, particularly in subjects with good glycemic control and limited microangiopathy.
Journal ArticleDOI
Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.
Abby R. Saniabadi,Hiroyuki Hanai,Ken Takeuchi,Kazuo Umemura,Mitsuyoshi Nakashima,Taro Adachi,Chikako Shima,Ingvar Bjarnason,Robert Löfberg +8 more
TL;DR: A long lasting effect on inflammatory cytokine generation,chemokine activities or immunomodulation is likely, but the precisemechanisms involved are not fully understood yet.
Journal ArticleDOI
Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study.
Hiroaki Shimokawa,Katsuhiko Hiramori,Hiroyuki Iinuma,Saichi Hosoda,Hiroshi Kishida,Hirofumi Osada,Takashi Katagiri,Kazunobu Yamauchi,Yoshiki Yui,Takazo Minamino,Mitsuyoshi Nakashima,Kazuzo Kato +11 more
TL;DR: In this article, the anti-anginal effect of fasudil, which is metabolized to a specific Rho-kinase inhibitor hydroxyfasudils after oral administration, was examined in patients with stable effort angina.
Journal Article
Antianginal effect of fasudit, a Rho-kinase inhibitor, in patients with stable effort angina : a multicenter study
TL;DR: Fasudil was well tolerated in both trials without any serious adverse reactions and a significant dose-response relation was noted across the treatment groups for the exercise tolerance index that was determined by the combined effect of exercise time and ST segment depression.